BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24815836)

  • 1. Dual role of podoplanin in oral cancer development.
    Cîrligeriu L; Cimpean AM; Raica M; Doroş CI
    In Vivo; 2014; 28(3):341-7. PubMed ID: 24815836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Podoplanin expression in oral squamous cell carcinoma and leukoplakia and its correlation with lymph vessels density].
    Zhang G; Guo ZL; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Aug; 44(8):488-91. PubMed ID: 19961757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podoplanin expression in tumor-free resection margins of oral squamous cell carcinomas: an immunohistochemical and fractal analysis study.
    Margaritescu C; Raica M; Pirici D; Simionescu C; Mogoanta L; Stinga AC; Stinga AS; Ribatti D
    Histol Histopathol; 2010 Jun; 25(6):701-11. PubMed ID: 20376776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx.
    Huber GF; Fritzsche FR; Züllig L; Storz M; Graf N; Haerle SK; Jochum W; Stoeckli SJ; Moch H
    Int J Cancer; 2011 Sep; 129(6):1404-9. PubMed ID: 21105028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of podoplanin expression in esophageal squamous cell carcinoma: a retrospective study.
    Tong L; Yuan S; Feng F; Zhang H
    Dis Esophagus; 2012 Jan; 25(1):72-80. PubMed ID: 21895849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podoplanin expression in advanced-stage gastric carcinoma and prognostic value of lymphatic microvessel density.
    Raica M; Ribatti D; Mogoanta L; Cimpean AM; Ioanovici S
    Neoplasma; 2008; 55(5):455-60. PubMed ID: 18665758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
    Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
    Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma.
    Mashhadiabbas F; Mahjour F; Mahjour SB; Fereidooni F; Hosseini FS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Aug; 114(2):240-50. PubMed ID: 22769410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
    Adachi Y; Nakamura H; Kitamura Y; Taniguchi Y; Araki K; Shomori K; Horie Y; Kurozawa Y; Ito H; Hayashi K
    Pathol Int; 2007 Apr; 57(4):171-7. PubMed ID: 17316411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia.
    D'souza B; Nayak R; Kotrashetti VS
    Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):132-139. PubMed ID: 27153448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas.
    Funayama A; Cheng J; Maruyama S; Yamazaki M; Kobayashi T; Syafriadi M; Kundu S; Shingaki S; Saito C; Saku T
    Pathobiology; 2011; 78(3):171-80. PubMed ID: 21613804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatics and D2-40/podoplanin expression in gastrointestinal stromal tumours of the stomach with and without lymph node metastasis: an immunohistochemical study with special reference to the Carney triad.
    Agaimy A; Carney JA
    J Clin Pathol; 2010 Mar; 63(3):229-34. PubMed ID: 20203222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphangiogenesis and podoplanin expression in oral squamous cell carcinoma and the associated lymph nodes.
    de Sousa SF; Gleber-Netto FO; de Oliveira-Neto HH; Batista AC; Nogueira Guimarães Abreu MH; de Aguiar MC
    Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):588-94. PubMed ID: 22495364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic vessel assessment by podoplanin (D2-40) immunohistochemistry in breast cancer.
    Wahal SP; Goel MM; Mehrotra R
    J Cancer Res Ther; 2015; 11(4):798-804. PubMed ID: 26881521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
    Kawaguchi H; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim E; Hong WK; Lippman SM; Mao L
    J Clin Oncol; 2008 Jan; 26(3):354-60. PubMed ID: 18202409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic vessel density and lymph node metastasis in prostate cancer.
    Zeng Y; Opeskin K; Horvath LG; Sutherland RL; Williams ED
    Prostate; 2005 Nov; 65(3):222-30. PubMed ID: 15948136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cell expression of podoplanin correlates with nodal metastasis in esophageal squamous cell carcinoma.
    Chuang WY; Yeh CJ; Wu YC; Chao YK; Liu YH; Tseng CK; Chang HK; Liu HP; Hsueh C
    Histol Histopathol; 2009 Aug; 24(8):1021-7. PubMed ID: 19554509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer--ROC curve analysis to find cut-off point.
    Donizy P; Rudno-Rudzinska J; Halon A; Dziegala M; Kabarowski J; Frejlich E; Dziegiel P; Kielan W; Matkowski R
    Anticancer Res; 2014 Jun; 34(6):3113-8. PubMed ID: 24922680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma.
    Kyzas PA; Geleff S; Batistatou A; Agnantis NJ; Stefanou D
    J Pathol; 2005 Jun; 206(2):170-7. PubMed ID: 15846845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of podoplanin in oral cancer and its association with poor clinical outcome.
    Yuan P; Temam S; El-Naggar A; Zhou X; Liu DD; Lee JJ; Mao L
    Cancer; 2006 Aug; 107(3):563-9. PubMed ID: 16804930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.